Other information

Strategy, appointments, major clinical, medical and regulatory advances, and partnerships: you can find all the latest Ipsen Group press releases here.

September 21, 2018

Ipsen relocating German affiliate to Munich

Events | News | Other information News Article

June 3, 2018

Boston and Paris – two rich ecosystems of R&D excellence

News | Other information News Article

June 3, 2018

Exelixis announces results from sub-group analyses of the phase 3 pivotal CELESTIAL trial of cabozantinib for advanced hepatocellular carcinoma presented at ASCO 2018

Other information | Press Releases News Article

May 30, 2018

Exelixis Announces U.S. FDA Accepts Supplemental New Drug Application for CABOMETYX (cabozantinib) in Previously Treated Advanced Hepatocellular Carcinoma

News | Other information | Press Releases News Article

May 22, 2018

IPSEN SPONSORS THE STROKE ACTION PLAN FOR EUROPE (2018-2030)

News | Other information | Press Releases News Article

Choose your location:

Choose a Language

Other information